Be Ready to Dispense Baqsimi for Very Low Blood Sugar

January 2020

Baqsimi (bak-SEE-mee) is a new INTRANASAL glucagon that will be a game changer for treating severe hypoglycemia.

Quick response is key. Very low blood sugar can cause confusion, seizures, and loss of consciousness...increasing risk of injury and death.

Glucagon injection kits have been the go-to for decades. But they require several steps to reconstitute and administer.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Practice Stamp Out Mishaps When Mailing or Delivering Rxs
Medication Errors Use Double Checks With Meds That Have Extended-Release Suffixes
Supplements Help Patients Avoid Problems With Cold and Flu Supplements
Hypertension Listen for Patients Asking When They Should Take Their BP Meds
Gastroenterology Steer Patients to the Pharmacist for Questions About EsopH for Acid Reflux
Cultural Awareness Optimize Communication With Transgender and Gender-Diverse Patients
Hypoglycemia Be Ready to Dispense Baqsimi for Very Low Blood Sugar
Autism Stay Alert for Mix-Ups With Meds for Autism Spectrum Disorder
Pneumonia Expect to See More Amoxicillin Rxs for Pneumonia
HIV & AIDS Watch for Patients Getting Meds to Prevent HIV After Exposure